Savant Capital, LLC Regenxbio Inc. Transaction History
Savant Capital, LLC
- $17.8 Billion
- Q3 2025
A detailed history of Savant Capital, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 26,707 shares of RGNX stock, worth $307,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,707
Previous 27,481
2.82%
Holding current value
$307,397
Previous $225,000
14.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGNX
# of Institutions
189Shares Held
44.3MCall Options Held
138KPut Options Held
117K-
Black Rock Inc. New York, NY8.61MShares$99.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.69MShares$54 Million4.99% of portfolio
-
Jpmorgan Chase & CO New York, NY4.04MShares$46.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.34MShares$38.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.98MShares$22.8 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $498M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...